Cell Line Development & Engineering Asia 2012 (Feb 21-23, SHANGHAI,CHINA)

Cell Line Development & Engineering Asia 2012– Advancing Asia’s Capabilities in Quality Biopharma Development

 

21-23 February 2012 | Grand Hyatt Shanghai, China

 

As Asia becomes a biologics and biosimilars powerhouse, there is a growing demand for cell lines to be used for clinical and industrial purpose. Find out the trends, updates and success stories from Chinese companies that have taken the internal cell line development route as well as from international experts talking about increasing efficiency and speed of development while reducing costs and achieving process optimization.

 

CELL LINE DEVELOPMENT & ENGINEERING ASIA brings together experts and top scientists from biopharmas, biotechs, CMOs and research institutes as well as leading technology providers from Asia and globally. The region’s 1st and ONLY focused Cell Line development and Engineering Asia provides a forum where industry experts share lessons learned through case studies, strategic discussion groups and interactive roundtables to collectively collaborate and provide solutions to your most pressing challenges. Bring back new ideas to do better business.

 

Co-located with: Antibodies Asia 2012– Expediting Development of Novel and Biosimilar Therapeutic Antibodies in Asia

 

Academic Keynote Speaker:

Prof Michael Betenbaugh

Professor and former Chair of Department, Chemical and Biomolecular Engineering,

Johns Hopkins University, USA

 

Industry Keynote Speaker:

Dr Jianguo Yang

Principal Scientist, Genzyme / Sanofi Aventis, USA

 

PLUS! Expert Presentations from:

Dr Lin Zhang, Associate Research Fellow, Pfizer, USA

Dr Zhiwei Song, Senior Scientist, BTI A*Star, Singapore

Dr Chichang Lee, Executive Director,Simcere Pharmaceuticals, China

Dr Rustom Mody, Executive Vice President,Intas Biopharmaceuticals, India

Dr Weidong Jiang, CSO and Vice President, Henlix Biopharmaceuticals, USA

Dr Feng Gao, Chief Operating Officer,AutekBio (Beijing), China

Dr Emmanuel Guerevitz, Chief Executive Officer, Amagino Biotechnology, Israel

 

Dr Ralf Schumacher, Head of Biologics Research, Pharma Research and Early Development, Roche Diagnostics, Germany

Dr Cheng Liu , Chief Executive Officer, Eureka Therapeutics, USA

Dr Steven Lee, Global Head of Biologics, Luye Pharmaceuticals, Singapore

Dr Baoping Wang , Vice President and Head of R&D, Novo Nordisk, China

Dr Yang Yuan Sheng, Research Scientist, BTI, A*Star, Singapore

Dr Noelle Sunstrom, Chief Executive Officer, Neuclone, Australia

Dr Shun Luo, President, JS Biosciences, China

 

Who should attend:

By Job Title :

• Directors, VPs, CEO

• Head of Process Development

• Head of R&D

• Head of Bioprocess/Biotechnology

• Scientists

• Researchers

• QA/QC Specialists

• Bioprocess Engineers

Why You Should Attend:

• Asia’s FIRST and ONLY conference focused on Cell Line Development and Engineering from

the leading company with established events in US and Europe

• Featuring case studies from biopharma, research institutes and biotechs to review available technologies, products and suppliers and to discuss cost effective and quality process development

• The most comprehensive event highlighting key challenges in cell line development and engineering including best practices, improving cell banking , optimising selection process and subsequent cell line development, IP and regulatory issues

• Explore collaboration opportunities with Asian biopharma and regional as well as global partners

• Learn from international experts, identify challenges and gaps in cell line development

• Review regulations from US, Europe and Asia

 

Key themes and issues include:

• Examining the Business and Regulatory Landscape

• Cell Line Development Approaches for Biosimilars

• Addressing Timeline Bottlenecks in Development

• Implementing Successful Cell Line Strategies

• Screening and Automation, Clone Selection, Expression and Cell Line Stability

• Optimizing Process Development

To find out more or to register your place, visit or email register@ibcasia.com.sg
or call +65 6508 2401 (Singapore)/+86 21 2326 3680 (China).

 

I am looking forward to welcoming you at the Cell Line Development & Engineering Asia 2012.

Kind Regards
Elle Quan
Conference Producer